Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma
- PMID: 12825822
- DOI: 10.1023/a:1023900802254
Practical problems with the collection and interpretation of serial quality of life assessments in patients with malignant glioma
Abstract
Objectives: To assess the problems involved with the collection and interpretation of serial collected health related quality of life assessments in patients with malignant glioma.
Patients and methods: One-hundred and fifty nine patients with malignant glioma from three Scottish neurosurgical centres in whom assessments of performance status, neurological impairment, mood, and quality of life had been recorded over a 6-month period were prospectively identified. The amount of missing data and the reasons for missing data were assessed. Characteristics of patients that were fully compliant with serial assessments were then compared with those that were not.
Results: Compliance with serial assessments (both patient and observer reported) was poor, dropping to less than 50% at 6 months. Observer reported measures showed a similar pattern of decline as patient reported measures. The largest single cause of missing data (approximately 70%) was due to administrative failure. Compliant patients were found to have a significantly greater probability of survival compared to non-compliant patients and were also found to be younger and fitter relative to the rest of the study population.
Conclusions: Studies utilising quality of life outcomes should give early consideration to minimising avoidable sources of missing data and recording the reasons for non-compliance. Quality of life studies basing conclusions on a complete case analysis should be wary of possible bias.
Similar articles
-
Causes and Consequences of Missing Health-Related Quality of Life Assessments in Patients Who Undergo Mechanical Circulatory Support Implantation: Insights From INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12):e003268. doi: 10.1161/CIRCOUTCOMES.116.003268. Circ Cardiovasc Qual Outcomes. 2017. PMID: 29246883 Free PMC article.
-
Health-related quality of life in high-grade glioma patients.Chin J Cancer. 2014 Jan;33(1):40-5. doi: 10.5732/cjc.013.10214. Chin J Cancer. 2014. PMID: 24384239 Free PMC article. Review.
-
Perioperative and Postoperative Quality of Life in Patients with Glioma-A Longitudinal Cohort Study.World Neurosurg. 2018 Sep;117:e465-e474. doi: 10.1016/j.wneu.2018.06.052. Epub 2018 Jun 18. World Neurosurg. 2018. PMID: 29920391
-
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):453-9. doi: 10.1016/0360-3016(95)93160-9. Int J Radiat Oncol Biol Phys. 1995. PMID: 7852106 Clinical Trial.
-
Missing quality of life data in cancer clinical trials: serious problems and challenges.Stat Med. 1998 Mar 15-Apr 15;17(5-7):517-32. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<517::aid-sim799>3.0.co;2-s. Stat Med. 1998. PMID: 9549801 Review.
Cited by
-
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide.J Neurooncol. 2013 Aug;114(1):111-6. doi: 10.1007/s11060-013-1159-6. Epub 2013 Jun 2. J Neurooncol. 2013. PMID: 23729276 Clinical Trial.
-
Impaired health-related quality of life in meningioma patients-a systematic review.Neuro Oncol. 2017 Jul 1;19(7):897-907. doi: 10.1093/neuonc/now250. Neuro Oncol. 2017. PMID: 28039363 Free PMC article.
-
Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review.J Neurooncol. 2011 Sep;104(3):639-46. doi: 10.1007/s11060-011-0565-x. Epub 2011 Apr 6. J Neurooncol. 2011. PMID: 21468776 Free PMC article. Review.
-
Quality of life in adults with brain tumors: current knowledge and future directions.Neuro Oncol. 2009 Jun;11(3):330-9. doi: 10.1215/15228517-2008-093. Epub 2008 Nov 10. Neuro Oncol. 2009. PMID: 19001097 Free PMC article. Review.
-
Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992).Clin Trials. 2016 Dec;13(6):612-620. doi: 10.1177/1740774516655101. Epub 2016 Jun 30. Clin Trials. 2016. PMID: 27365012 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical